Articles > Newspapers > International Newspapers, Local Markets A-Lh > AsiaPulse News news wires > January 2009

Article: BRIEFING - ASIA HEALTH - JAN 19, 2009.

Article from:
AsiaPulse News
Article date:
January 19, 2009
Copyright

An executive briefing on Health for Jan 19, 2009, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.

INDIAN PHARMA LUPIN GETS USFDA NOD FOR LEVETIRACTAM TABLET

MUMBAI - Indian drug maker Lupin (BSE:500257) on Friday said it has received final approval from the US drug regulator for marketing its Levetiractam tablets, which is used in the treatment of epilepsy.

In a filing to the Bombay Stock Exchange, the company said that its US subsidiary Lupin Pharmaceuticals Inc has received final approval from the United States Food and Drug Agency (USFDA) ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: GLENMARK PHARMACEUTICALS, TEIJIN PHARMA ANNOUNCE ...
The Hindustan Times;  April 26, 2005 ;     700+ words ... ... after commercial launch, Teijin Pharma will pay Glenmark annual ... This collaboration with Teijin Pharma is in line with our strategy ... company of high repute like Teijin Pharma that has consistently ... through HT Syndication, New Delhi.

Article: Teijin Pharma Licenses Marketing Rights of TMX-67 ...
M2 Presswire;  May 12, 2009 ;     700+ words ...M2 PRESSWIRE-12 May 2009-Teijin Pharma Limited: Teijin Pharma Licenses Marketing Rights of TMX-67 in Taiwan to ... 1994-2009 M2 COMMUNICATIONS LTD RDATE:12052009 Teijin Pharma Limited announced that it has signed an exclusive ...

Article: TEIJIN PHARMA AND SCYNEXIS SIGN RESEARCH AGREEMENT.
AsiaPulse News;  October 13, 2005 ;     700+ words ... ... development company, today announced that Teijin Pharma Limited, an R&D-oriented ... and analytical chemistry services to Teijin Pharma's research programs. The financial ... disclosed. The agreement provides Teijin Pharma with dedicated chemistry resources ...

Article: Teijin Pharma and SCYNEXIS Sign Research Agreement.
PR Newswire;  October 13, 2005 ;     700+ words ... ... development company, today announced that Teijin Pharma Limited, an R&D-oriented ... and analytical chemistry services to Teijin Pharma's research programs. The financial ... disclosed. The agreement provides Teijin Pharma with dedicated chemistry resources ...

Article: Teijin Pharma Deploys Datastream 7i in ...
Business Wire;  October 14, 2004 ;     700+ words ... ... NASDAQ: DSTM) today announced that Teijin Pharma Limited is deploying the Datastream ... Iwakuni, Yamaguchi Prefecture, Japan. Teijin Pharma chose Datastream because of its demonstrated ... staff of approximately 1,600 people, Teijin Pharma is a member of the Teijin Industrial ...

Article: Nissan Chemical Industries and Teijin Pharma ...
M2 Presswire;  March 5, 2009 ;     700+ words ... ... Limited: Nissan Chemical Industries and Teijin Pharma License Ex-Japan Rights for Atrial ... Nissan Chemical Industries") and Teijin Pharma Ltd. (Head office: Chiyoda-ku ... President: Osamu Nishikawa, hereafter "Teijin Pharma") signed a license agreement with ...

Article: Teijin Pharma and Takeda Announces ULORIC[R] ...
Business Wire;  February 14, 2009 ;     700+ words ...TOKYO & OSAKA, Japan -- Teijin Pharma Limited (Head office: Chiyoda-ku ... President: Osamu Nishikawa, hereafter "Teijin Pharma") and Takeda Pharmaceutical Company ... today that on February 13, 2009, Teijin Pharma's U.S. licensee for febuxostat ...

Article: Teijin Pharma and Takeda Announces ULORIC[R] ...
Biotech Week;  March 4, 2009 ;     700+ words ...Teijin Pharma Limited (Head office: Chiyoda-ku, Tokyo; President ... the product, ULORIC[R] in the U.S (see also Teijin Pharma Limited). Febuxostat was discovered by Teijin Pharma after intensive research, and is an oral, once ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives